ANTISTAPHYLOCOCCAL ACTIVITY OF RIFAMPIN-BONDED GELATIN-IMPREGNATED DACRON GRAFTS

被引:46
作者
GAHTAN, V
ESSES, GE
BANDYK, DF
NELSON, RT
DUPONT, E
MILLS, JL
机构
[1] JAMES A HALEY VET ADM MED CTR, SURG SERV, TAMPA, FL 33606 USA
[2] UNIV ARIZONA, HLTH SCI CTR, TUCSON, AZ USA
关键词
D O I
10.1006/jsre.1995.1017
中图分类号
R61 [外科手术学];
学科分类号
摘要
The affinity of rifampin to bond to Dacron permits implantation of a vascular prosthesis with anti-staphylococcal bioactivity. The performance of rifampin-bonded Dacron grafts was evaluated in vitro and in vivo to develop a bonding technique with optimal graft bioactivity which was then used for in situ reconstruction of a biofilm graft infection. In vitro bioactivity was measured at 24-hr intervals for three types of Dacron prostheses (plain, gelatin, and collagen-impregnated) exposed to rifampin at varied concentrations and immersion times. Gelatin-impregnated grafts demonstrated superior bioactivity (P < 0.05). Rifampin concentration and graft type had a greater effect on bioactivity than immersion time (P < 0.01). Gelatin-impregnated grafts immersed in a 60 mg/ml rifampin solution for 15 min produced optimum bioactivity. Six grafts prepared in this fashion were used to replace the canine aorta. The level and duration of in vivo antistaphylococcal activity to Staphylococcus aureus and Staphylococcus epidermidis were less (P < 0.05) than those measured in vitro, but rifampin levels exceeded the study strain maximum inhibitory concentration for up to 48 hr. In a canine model, the rifampin-bonded gelatin-impregnated (N = 14) or nonbonded control (N = 10) grafts were used as in situ replacement for an established aortic graft infection caused by S. epidermidis, Replacement with a rifampin-bonded graft resulted in successful anatomic healing of perigraft and anastomotic tissue. Persistent biofilm colonization was confirmed in 8 of 10 controls versus 4 of 14 rifampin-bonded grafts (P < 0.02). Rifampin-bonding to Dacron grafts by passive absorption was practical and produced a minimum of 48 hr duration of in vivo antistaphylococcal activity. This level was sufficient to reduce prosthesis colonization when used for in situ replacement of a low-grade graft infection. (C) 1995 Academic Press, Inc.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 19 条
[1]  
ASHTON TR, 1990, P SOC BIOMATER, V13, P235
[2]  
AVRAMOVIC J, 1992, J CARDIOVASC SURG, V33, P70
[3]   RIFAMPICIN IMPREGNATION OF A PROTEIN-SEALED DACRON GRAFT - AN INFECTION-RESISTANT PROSTHETIC VASCULAR GRAFT [J].
AVRAMOVIC, JR ;
FLETCHER, JP .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1991, 61 (06) :436-440
[4]  
BANDYK DF, 1991, J VASC SURG, V13, P575
[5]  
CHERVU A, 1991, J VASC SURG, V13, P897
[6]   PREVENTION OF GRAFT INFECTION BY USE OF PROSTHESES BONDED WITH A RIFAMPIN/COLLAGEN RELEASE SYSTEM [J].
CHERVU, A ;
MOORE, WS ;
GELABERT, HA ;
COLBURN, MD ;
CHVAPIL, M .
JOURNAL OF VASCULAR SURGERY, 1991, 14 (04) :521-525
[7]   USE OF AN ANTIBIOTIC-BONDED GRAFT FOR INSITU RECONSTRUCTION AFTER PROSTHETIC GRAFT INFECTIONS [J].
COLBURN, MD ;
MOORE, WS ;
CHVAPIL, M ;
GELABERT, HA ;
QUINONESBALDRICH, WJ .
JOURNAL OF VASCULAR SURGERY, 1992, 16 (04) :651-660
[8]  
Drury J K, 1987, Ann Vasc Surg, V1, P542, DOI 10.1016/S0890-5096(06)61437-4
[9]  
FARR B, 1982, MED CLIN N AM, V66, P156
[10]  
FREYRIE A, 1992, INT ANGIOL, V11, P113